The Value of White Cell Inflammatory Biomarkers as Potential Predictors for Diabetic Retinopathy in Type 2 Diabetes Mellitus (T2DM).

The pathogenesis of diabetic retinopathy is still challenging, with recent evidence proving the key role of inflammation in the damage of the retinal neurovascular unit. This study aims to investigate the predictive value of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte (PLR), lymphocyte-to-monocyte ratio (LMR), and systemic inflammation index (SII) for diabetic retinopathy (DR) and its severity. We performed a retrospective study on 129 T2DM patients, divided into three groups: without retinopathy (NDR), non-proliferative DR (NPDR), and proliferative DR (PDR). NLR, MLR, and SII were significantly higher in the PDR group when compared to NDR and NPDR (3.2 ± 1.6 vs. 2.4 ± 0.9 and 2.4 ± 1.1; p = 0.005; 0.376 ± 0.216 vs. 0.269 ± 0.083 and 0.275 ± 0.111, p = 0.001; 754.4 ± 514.4 vs. 551.5 ± 215.1 and 560.3 ± 248.6, p = 0.013, respectively). PDR was correlated with serum creatinine (OR: 2.551), NLR (OR: 1.645), MPV (OR: 1.41), and duration of diabetes (OR: 1.301). Logistic regression analysis identified three predictive models with very good discrimination power for PDR (AUC ROC of 0.803, 0.809, and 0.830, respectively): combining duration of diabetes with NLR, MLR, and, respectively, PLR, MPV, and serum creatinine. NLR, MPV, SII, and LMR were associated with PDR and could be useful when integrated into comprehensive risk prediction models.

[1]  F. Chen,et al.  Reference intervals of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio during normal pregnancy in China. , 2023, European review for medical and pharmacological sciences.

[2]  Zheng Li,et al.  Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults , 2023, Journal of clinical medicine.

[3]  C. Mekonnen,et al.  Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021 , 2023, BMC Ophthalmology.

[4]  T. Peto,et al.  Inclusion of diabetic retinopathy screening strategies in national-level diabetes care planning in low- and middle-income countries: a scoping review , 2023, Health Research Policy and Systems.

[5]  K. Gomułka,et al.  The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy—A Short Review , 2023, International journal of molecular sciences.

[6]  Yancheng Song,et al.  Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018 , 2022, Frontiers in Endocrinology.

[7]  Qing Shen,et al.  Association of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes: A Cross-Sectional Study , 2022, Therapeutics and clinical risk management.

[8]  Dong Wang,et al.  Association of Red Blood Cell Distribution Width with Stroke Prognosis Among Patients with Small Artery Occlusion: A Hospital-Based Prospective Follow-Up Study , 2022, International journal of general medicine.

[9]  Xi Zhang,et al.  The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the National Health and nutrition examination survey , 2022, BMC Ophthalmology.

[10]  M. Ola,et al.  Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration , 2022, Frontiers in Neuroscience.

[11]  Odunayo O. Mugisho,et al.  Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review , 2022, BMC Ophthalmology.

[12]  Huan Wang,et al.  Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes , 2022, Journal of translational medicine.

[13]  B. Kim,et al.  Recent progress in polymeric non-invasive insulin delivery. , 2022, International journal of biological macromolecules.

[14]  M. Rizzo,et al.  The Role of Fructose as a Cardiovascular Risk Factor: An Update , 2022, Metabolites.

[15]  X. Qin,et al.  Predictive Values of the Selected Inflammatory Indexes in Colon Cancer , 2022, Cancer control : journal of the Moffitt Cancer Center.

[16]  C. Bondor,et al.  Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) in Various Respiratory Diseases: A Retrospective Analysis , 2021, Diagnostics.

[17]  Dong-mei Zhang,et al.  Correlation between ultrawide-field fluorescence contrast results and white blood cell indexes in diabetic retinopathy , 2021, BMC Ophthalmology.

[18]  M. Rizzo,et al.  Significance of Neutrophil to Lymphocyte Ratio (NLR) and Platelet Lymphocyte Ratio (PLR) in Diabetic Foot Ulcer and Potential New Therapeutic Targets , 2021, The international journal of lower extremity wounds.

[19]  B. Kurtul,et al.  The diagnostic value of systemic immune-inflammation index in diabetic macular oedema , 2021, Clinical & experimental optometry.

[20]  Y. Garfias,et al.  Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes , 2021, BMJ Open Ophthalmology.

[21]  H. Cao,et al.  The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[22]  Wen-Yue Liu,et al.  Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations , 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

[23]  Hui Wu,et al.  Clinical and predictive significance of Plasma Fibrinogen Concentrations combined Monocyte-lymphocyte ratio in patients with Diabetic Retinopathy , 2021, International journal of medical sciences.

[24]  L. Singh,et al.  Metabolic Dysregulation and Neurovascular Dysfunction in Diabetic Retinopathy , 2020, Antioxidants.

[25]  Y. Kawabata,et al.  Comparison of the prognostic value of immunoinflammation-based biomarkers in patients with gastric cancer , 2020, Oncotarget.

[26]  Yingli Lu,et al.  The unique association between the level of peripheral blood monocytes and the prevalence of diabetic retinopathy: a cross-sectional study , 2020, Journal of Translational Medicine.

[27]  Yue Yin,et al.  Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history , 2020, Diabetology & Metabolic Syndrome.

[28]  J. Shaw,et al.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.

[29]  K. Tekin,et al.  The Optimal Cutoff Value of Neutrophil/Lymphocyte Ratio for Severe Grades of Diabetic Retinopathy , 2019, Beyoglu eye journal.

[30]  R. Alizadeh-Navaei,et al.  Normal values of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio among Iranian population: Results of Tabari cohort , 2019, Caspian journal of internal medicine.

[31]  Xuerui Tan,et al.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China , 2019, BMC Cardiovascular Disorders.

[32]  Yuxiang Hu,et al.  Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with diabetic macular edema treated with ranibizumab , 2019, BMC Ophthalmology.

[33]  H. Goyal,et al.  Normal Reference Intervals of Neutrophil-To-Lymphocyte Ratio, Platelet-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Systemic Immune Inflammation Index in Healthy Adults: a Large Multi-Center Study from Western China. , 2019, Clinical laboratory.

[34]  R. Qayyum,et al.  Platelet-lymphocyte ratio (PLR) and all-cause mortality in general population: insights from national health and nutrition education survey , 2019, Platelets.

[35]  Yuquan Wei,et al.  Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors , 2018, Oncotarget.

[36]  Sung-il Cho,et al.  Treatment variation related to comorbidity and complications in type 2 diabetes , 2018, Medicine.

[37]  B. Stricker,et al.  Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study , 2018, Scientific Reports.

[38]  Jennifer K. Sun,et al.  Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. , 2018, Ophthalmology.

[39]  P. Fort,et al.  Role of Inflammation in Diabetic Retinopathy , 2018, International journal of molecular sciences.

[40]  F. He,et al.  Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: A posteriori and big‐data‐based , 2018, Journal of clinical laboratory analysis.

[41]  Ming-Lin Liu,et al.  Pathogenic roles of microvesicles in diabetic retinopathy , 2017, Acta Pharmacologica Sinica.

[42]  A. Buch,et al.  Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients , 2017, Journal of laboratory physicians.

[43]  Shengping Yang,et al.  The receiver operating characteristic (ROC) curve , 2017 .

[44]  S. Chittawar,et al.  Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes , 2017, Indian journal of endocrinology and metabolism.

[45]  Dominique Latinne,et al.  What is the normal value of the neutrophil-to-lymphocyte ratio? , 2017, BMC Research Notes.

[46]  Ji-Feng Feng,et al.  Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus , 2017, Medicine.

[47]  B. Goker,et al.  The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis , 2016, Journal of clinical laboratory analysis.

[48]  M. Schwartz,et al.  The retinal pigment epithelium as a gateway for monocyte trafficking into the eye , 2016, The EMBO journal.

[49]  W. Teng,et al.  Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy , 2015, International journal of environmental research and public health.

[50]  C. Costagliola,et al.  Diabetic Retinopathy: Vascular and Inflammatory Disease , 2015, Journal of diabetes research.

[51]  A. Dascalu,et al.  Interleukin 6 and lipopolysaccharide binding protein - markers of inflammation in acute appendicitis. , 2013, Chirurgia.

[52]  A. Saxena,et al.  Advanced glycation end products and diabetic retinopathy , 2012, Journal of ocular biology, diseases, and informatics.

[53]  Prof. Dr. Asher. Fawwad,et al.  Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients , 2012, Pakistan journal of medical sciences.

[54]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[55]  Matthew D. Davis,et al.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.

[56]  Wenfang Zhang,et al.  The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a Meta-analysis and systematic review. , 2019, International journal of ophthalmology.